tickstock newsroom AI
Articles
SkinBioTherapeutics said it's board has now completed its investigation
It has also confirmed the appointment of a new auditor, Saffrey, and expects to announce further details shortly.
Vesuvius maintains full year guidance after slightly stronger start, expects stronger H2
Revenue and trading profit were slightly ahead of last year, on a constant currency basis, and it anticipates the second half will be stronger than the first.
Nuformix results highlight progress as it advances 'viable and attractive' candidates
"Our ongoing research and progressive external discussions validate that inhaled treatment of IPF via NXP002 remains a viable and attractive concept, and the FDA orphan designation is helping advance partnering discussions," said Dr Dan Gooding.
Johnson Matthey expects 2027 profit growth as cash flow rose last year
IQE completes £81m fundraising
IQE raised £81m through the issue of 332.18m Fundraising Shares, lifting its issued share capital to 1.31bn shares and diluting existing holders by 25.3%.
The Premarket Brief: SSE earnings hit upper guidance as capex reaches £3.6bn, Johnson Matthey, Cooks Coffee
A busy morning for corporate news ahead of the open, led by SSE's full-year results landing at the upper end of guidance alongside a step-change in capital deployment, while Johnson Matthey moved to reshape its Clean Air Solutions division with a significant transatlantic acquisition. Cooks Coffee a
Cooks Coffee revenue jumps 84% as rollout of new sites continues
CEO Aiden Keegan said "Growth for the Esquires brand continues to significantly exceed reported industry growth in both core markets."
SSE reports FY earnings at upper end of guidance whilst capex climbs to £3.6bn
"By operating our business efficiently and optimally, while accelerating electrification and building energy infrastructure to unlock homegrown renewables, we are strengthening energy security and lowering system costs over time," said Martin Pibworth, Chief Executive.
Johnson Matthey to buy Cormetech for $360m to bulk up Clean Air Solutions
Mining Today: Kendrick, Richmond Hill Resources, Firering Strategic Minerals, Tungsten West, Sovereign Metals
Rare earths and gold exploration dominated the small-cap mining agenda on Wednesday.
Health & Bio Today: ImmuPharma narrows loss with P140 partnership push, Physiomics, ValiRx, AstraZeneca
A mix of clinical progress and corporate milestones shaped the health and biotech small-cap session, with ImmuPharma reporting a narrowed annual loss and flagging a post-period fundraise as it targets a commercial deal for its lead lupus asset, while Physiomics won a string of new modelling contract
Oil & Gas Today: Synergia, Deltic Energy, Europa Oil & Gas, Arrow Exploration, Gran Tierra Energy
A busy session for small-cap oil and gas names was headlined by operational progress in India, where Synergia Energy completed four legacy well workovers at its Cambay block.
Oil price respite as hopes grow for Strait of Hormuz reopening
Crude oil prices fell to a five‑week low on Wednesday, after reports that a potential US‑Iran agreement could lead to the reopening of shipping through the Strait of Hormuz.
RTC Group shares dropped sharply after AGM statement
The workforce supplier cautioned that elevated energy prices have materially lowered demand for temporary labour.
Cohort shares boosted as it showed FY26 financials beat expectations
"Cohort performed strongly in 2025/26, exceeding market expectations and our closing order book has reached a new record level with encouraging prospects for further orders," Andrew Thomis, Chief Executive, said.
Synergia completes four Cambay well workovers and advances planning for new well
Arc Minerals shares rally thanks to Zambian settlement
The settlement ends eight court cases in Zambia and includes a conditional US$200,000 deferred payment tied to a JORC resource milestone.
Panmure keeps Buy on Pets at Home after retail shows visible turnaround
Panmure reiterates its Buy on Pets at Home Group with a 300p price target after FY26 results showed Vet profit growth and signs of a retail recovery that leave management comfortable with FY27 consensus underlying PBT of £98m.
IQE is tipped to monetise big opportunities
The London-listed semiconductor firm is well placed to monetise strong end‑market demand; that's according to a bullish note from DB.
Stockbroker tips the developer of the "next UK mine" as a 'Buy'
Zeus Capital has initiated coverage of Tungsten West with a BUY, arguing a US$25m bridge loan and progress on commissioning materially de‑risk the Hemerdon restart.